# HedgePath Pharmaceuticals, Inc.: Form D filing

HedgePath Pharmaceuticals, Inc., a pharmaceuticals company in Tampa, FL, filed a Form D with the SEC in 2016. The latest, on April 22, 2016, reports $600,000 sold of a $5.5 million offering to 3 investors.

Find out what HedgePath Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20HedgePath%20Pharmaceuticals%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=HedgePath%20Pharmaceuticals%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fhedgepath-pharmaceuticals-inc-1042418)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20HedgePath%20Pharmaceuticals%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=HedgePath%20Pharmaceuticals%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fhedgepath-pharmaceuticals-inc-1042418)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Florida](https://specstream.ai/data/form-d/state/florida): 2,702 rows, by operating companies, filed since November 1, 2024, $107.02, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/florida
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 324 SOUTH HYDE PARK AVENUE, SUITE 350, Tampa, FL, 33606
- Phone: (813) 864-2559
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(c)
- SEC identifier (CIK): 1042418

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Apr 22, 2016 | New notice | $5,500,000 | $600,000 | $4,900,000 | 3 | Apr 11, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1042418/000146581816000103/0001465818-16-000103-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Samuel P. Sears, Jr. | Director |  |
| R. Dana Ono, MD | Director |  |
| Frank E. O'Donnell, Jr., MD | Executive Officer, Director |  |
| Nicholas J. Virca | Executive Officer |  |
| W. Mark Watson, CPA | Director |  |
| Garrison J. Hasara, CPA | Executive Officer |  |
| Stefan J. Cross | Director |  |

## Other pharmaceuticals companies in Florida that filed recently

- [GOA Therapeutics Corp](https://specstream.ai/data/form-d/company/goa-therapeutics-corp-2131824) $300,000 · Nov 5, 2026
- [DalCor Pharmaceuticals US, LLC](https://specstream.ai/data/form-d/company/dalcor-pharmaceuticals-us-llc-1673368) $7 million · Aug 28, 2026

[Every Form D from the week of Apr 18, 2016](https://specstream.ai/data/form-d/week/2016-04-18) · [All recent filings in Florida](https://specstream.ai/data/form-d/state/florida) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what HedgePath Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).